Sildenafil Citrate 100mg
Vardenafil 20mg
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

SILVITRA

Description: SILVITRA is a medication manufactured by RSM Pharma containing the active substances Sildenafil and Vardenafil. It is available in tablet form, with each tablet containing a combination of Sildenafil and Vardenafil, totaling 120mg. SILVITRA is designed to provide a dual-action approach to the treatment of erectile dysfunction (ED) by combining two potent phosphodiesterase type 5 (PDE5) inhibitors.

Active Substances: SILVITRA contains two active substances:

1. Sildenafil: Sildenafil is a well-known PDE5 inhibitor used in the treatment of erectile dysfunction. It works by increasing blood flow to the penis by inhibiting the enzyme PDE5, allowing for improved erectile function and the ability to achieve and maintain an erection during sexual stimulation.
2. Vardenafil: Vardenafil is another PDE5 inhibitor with similar mechanisms of action to Sildenafil. It also promotes increased blood flow to the penis, aiding in the treatment of erectile dysfunction and enhancing sexual performance.

Medical Uses: SILVITRA is indicated for the treatment of erectile dysfunction (ED) in adult men. It is prescribed to men experiencing difficulties in achieving or maintaining an erection sufficient for sexual activity. By combining Sildenafil and Vardenafil, SILVITRA offers a synergistic effect, potentially providing better efficacy and response compared to single-agent therapies.

Administration: SILVITRA tablets are taken orally with water, typically as needed, approximately 30-60 minutes before anticipated sexual activity. The dosage may vary depending on individual response and tolerance to the medication. The recommended starting dose of SILVITRA is usually one tablet containing 120mg of the combined active substances. It is essential to follow the dosage instructions provided by a healthcare professional.

Storage: SILVITRA tablets should be stored at room temperature (between 20°C and 25°C) in a dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use SILVITRA beyond its expiration date.

Manufacturer: SILVITRA is manufactured by RSM Pharma, a reputable pharmaceutical company known for producing high-quality medications. RSM Pharma adheres to strict manufacturing standards to ensure the safety, efficacy, and reliability of their products.

Precautions:

• SILVITRA should only be used under the supervision of a qualified healthcare professional.
• Patients with underlying medical conditions such as cardiovascular disease or those taking medications containing nitrates should use SILVITRA with caution due to the potential for interactions.
• Individuals with a history of allergic reactions to Sildenafil, Vardenafil, or other PDE5 inhibitors should avoid using SILVITRA.

Side Effects: Common side effects of SILVITRA may include:

• Headache
• Flushing
• Indigestion
• Nasal congestion
• Dizziness or lightheadedness

Serious side effects such as priapism (prolonged erection lasting more than four hours) or sudden vision loss are rare but require immediate medical attention. Patients should seek medical help if they experience any severe or persistent side effects while using SILVITRA.

Disclaimer: SILVITRA should only be used under the supervision of a qualified healthcare professional for its intended medical purposes. This description provides general information about the medication and its uses and should not replace medical advice from a healthcare provider.